- Home
- EWCZ vs CVRX Comparison
EWCZ vs CVRX Comparison
Compare EWCZ & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- CVRX
- Stock Information
- Founded
- EWCZ 2004
- CVRX 2000
- Country
- EWCZ United States
- CVRX United States
- Employees
- EWCZ N/A
- CVRX N/A
- Industry
- EWCZ Package Goods/Cosmetics
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EWCZ Consumer Discretionary
- CVRX Health Care
- Exchange
- EWCZ Nasdaq
- CVRX Nasdaq
- Market Cap
- EWCZ 275.7M
- CVRX 311.3M
- IPO Year
- EWCZ 2021
- CVRX 2021
- Fundamental
- Price
- EWCZ $5.34
- CVRX $12.90
- Analyst Decision
- EWCZ Buy
- CVRX Buy
- Analyst Count
- EWCZ 7
- CVRX 7
- Target Price
- EWCZ $7.36
- CVRX $16.67
- AVG Volume (30 Days)
- EWCZ 1.1M
- CVRX 169.7K
- Earning Date
- EWCZ 11-14-2024
- CVRX 01-23-2025
- Dividend Yield
- EWCZ N/A
- CVRX N/A
- EPS Growth
- EWCZ 62.57
- CVRX N/A
- EPS
- EWCZ 0.23
- CVRX N/A
- Revenue
- EWCZ $223,500,000.00
- CVRX $47,255,000.00
- Revenue This Year
- EWCZ $1.03
- CVRX $31.78
- Revenue Next Year
- EWCZ $2.34
- CVRX $26.42
- P/E Ratio
- EWCZ $23.22
- CVRX N/A
- Revenue Growth
- EWCZ 2.42
- CVRX 34.38
- 52 Week Low
- EWCZ $4.80
- CVRX $6.40
- 52 Week High
- EWCZ $16.07
- CVRX $33.14
- Technical
- Relative Strength Index (RSI)
- EWCZ 37.65
- CVRX 46.81
- Support Level
- EWCZ $4.90
- CVRX $11.39
- Resistance Level
- EWCZ $6.74
- CVRX $13.68
- Average True Range (ATR)
- EWCZ 0.37
- CVRX 0.83
- MACD
- EWCZ -0.06
- CVRX -0.21
- Stochastic Oscillator
- EWCZ 23.98
- CVRX 42.02
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.